Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price
PTGX•Inducement awards granted to two new hires
Protagonist Therapeutics granted inducement equity awards on Aug. 17, 2026 to two newly hired employees.
Awards covered options for 5,675 shares and RSUs for 1,500 shares under its amended and restated inducement plan.
Options carry an exercise price of $155.1, matching the Aug. 17 Nasdaq closing price.
Option vesting runs four years: 25% after one year, with the balance vesting monthly over the next three years.
RSUs vest 25% annually over four years.
